Login
Toggle navigation
Videos
Categories
Trending
Executive Interview - Paion - Wolfgang Soehngen, CEO, Paion
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Discusses the group’s strategy including partnership deals with Cosmo and Mundipharma
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Unlocking Global Value: Insights from Gerard O’Reilly on the Value Premium Outpacing Growth Premium in Global Markets
00:10:00
Adevinta Finalizes $9.2 Billion Acquisition of eBay Classifieds | Rolv Erik Ryssdal, CEO , Adevinta.
00:10:00
Jean Salata on Private Equity Trends, Valuations, and Investment Opportunities | Jean Salata, CEO, Baring Private Equity Asia Ltd.
00:10:00
Madryn Asset Management is a leading alternative asset management firm that invests in innovative healthcare companies specializing in unique and transformative products, technologies, and services. The firm draws on its extensive and diverse experience s
00:10:00
Silver Project PEA Exceeds Expectations with 85.7% IRR and $1.14B NPV
00:10:00
A Conversation with PIMCO's CEO on Economic Outlook, Investment Strategy, and Global Dynamics | Emmanuel Roman, CEO, PIMCO.
00:10:00
Counting Our Blessings: End-of-Year Checklist and Financial Guidance
00:10:00
Don't more minorities launch VC backed companies|Rachel ten Brink,Founder and General Partner,Red Bike Capital
00:10:00
Buckingham Connects: May 2022 Webcast | Jonathan Abner - WEALTH ADVISOR of Buckingham Strategic Wealth
00:10:00
EP Wealth Advisors: Weekly Market Insights | RYAN PARKER - CEO of EP Wealth Advisors
00:10:00
Exploring High-Potential Gold and Lithium Projects in Quebec and Nunavik
00:10:00
The Value of Hiring a Financial Advisor: Objectivity and Expertise | Brooklyn Brock, Founder, Ellevate Advisors LLC.